In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors. 2012

Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
Department of Diagnostic and Interventional Radiology, Osaka University Graduate School of Medicine, Osaka, Japan. n-maeda@radiol.med.osaka-u.ac.jp

OBJECTIVE To investigate the pharmacokinetics and efficacy of chemoembolization with a cisplatin-loaded superabsorbent polymer (SAP) suspension in a rabbit model with transplanted liver VX2 tumors. METHODS VX2 tumors were implanted into the left lobe of the liver in eight rabbits. Embolization of the proper hepatic artery was performed with cisplatin-loaded or unloaded SAP. In the cisplatin-loaded SAP group (n = 4), 5 mg of SAP (106-150 μm) loading 2.35 mg of cisplatin and 0.5 mL of ionic contrast material (ioxaglic acid 320 mgI/mL) was injected into the proper hepatic artery. In the control group (hepatic arterial infusion [HAI] + SAP; n = 4), 5 mg of SAP loading 0.5 mL of ioxaglic acid alone was injected after a bolus infusion of an equivalent amount of cisplatin. Sequential change of the plasma platinum concentration within the first 24 hours was measured. Blood sampling and histopathologic examination were performed at 1-week follow-up. Magnetic resonance (MR) images were used to calculate the growth rate of the VX2 tumor. RESULTS All animals underwent successful embolization. Both total and free plasma platinum mean concentrations within the first 24 hours remained lower in the cisplatin-loaded SAP group, although without statistical significance (P > .05). The mean tumor growth rate was significantly lower in the cisplatin-loaded SAP group than the control group (20% vs 116%; P = .049). Histopathologic examination revealed coagulative necrosis to nontumorous liver parenchyma in two rabbits in the cisplatin-loaded SAP group, although no deaths occurred. CONCLUSIONS These results suggested that chemoembolization with cisplatin-loaded SAP was a safe and tolerable treatment and was more effective in suppressing the tumor growth.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007485 Ioxaglic Acid A low-osmolar, ionic contrast medium used in various radiographic procedures. Ioxaglate,Ioxaglate Meglumine,Ioxaglate Sodium,Hexabrix,Ioxaglic Acid Monosodium Salt,Ioxaglic Acid, Calcium Salt (2:1),Methylglucamine Ioxaglate,P-286 (Contrast Media),P286 (Contrast Media),Ioxaglate, Methylglucamine,Meglumine, Ioxaglate
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D011145 Polyvinyls POLYMERS derived from the monomer VINYL COMPOUNDS. Polyvinyl
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier

Related Publications

Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
June 2021, Molecular and clinical oncology,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
February 2017, Abdominal radiology (New York),
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
June 2011, Cardiovascular and interventional radiology,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
May 2017, Abdominal radiology (New York),
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
October 2011, Cardiovascular and interventional radiology,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
December 2015, Japanese journal of radiology,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
May 2012, Hepatology research : the official journal of the Japan Society of Hepatology,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
August 1986, Journal of pharmaceutical sciences,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
December 1994, Pharmaceutical research,
Noboru Maeda, and Keigo Osuga, and Kouki Shimazu, and Eiichi Morii, and Koji Mikami, and Shinichi Hori, and Tetsuro Nakazawa, and Hiroki Higashihara, and Kaname Tomoda, and Hironobu Nakamura, and Noriyuki Tomiyama
November 2020, Pharmaceutical development and technology,
Copied contents to your clipboard!